National Institutes of Health Grants
598 open grant opportunities from National Institutes of Health, from Grants.gov — each with a plain-English summary of who qualifies, the deadline, and the award size.
Biomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)
Due Jan 29, 2029National Institutes of Health · Amount varies
This NIH/NIGMS RM1 grant funds Biomedical Technology Optimization and Dissemination Centers to refine late-stage research technologies and sustainably share them with the wider biomedical research community. Applicants should be leaders in their technology field and within the NIGMS mission. Foreign organizations and foreign components of U.S. organizations are not eligible to apply, though foreign components within a project may be allowed.
ResearchersSchools & universitiesNarrow eligibilityMaximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI)
Due Feb 6, 2029National Institutes of Health · Amount varies
This NIH/NIGMS award (MIRA for Early Stage Investigators) funds early-career biomedical researchers at U.S. institutions to run an independent research program aligned with the NIGMS mission. It is aimed at Early Stage Investigators, so it is restrictive by career stage. Non-U.S. (foreign) institutions and foreign components of U.S. organizations are not eligible to apply, though foreign components within projects may be allowed per NIH policy.
ResearchersSchools & universitiesNarrow eligibilityHEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)
Due Feb 9, 2029National Institutes of Health · Amount varies
This NIH HEAL Initiative R61/R33 grant funds action-oriented research that translates addiction epidemiology, prevention, treatment, and recovery findings into practice to address the opioid crisis and overdose. Projects can target individual, provider, organizational, community, or system levels. Foreign organizations and foreign components of U.S. organizations are not eligible to apply, though foreign components within a project may be allowed.
ResearchersSchools & universitiesNarrow eligibilityHEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
Due Feb 20, 2029National Institutes of Health · Amount varies
This NIH HEAL Initiative UG3/UH3 cooperative agreement funds preclinical optimization and development of safe, non-addictive small-molecule and biologic therapeutics for treating pain, advancing candidates toward Phase II trials. Applicants must already have a promising lead candidate, a strong biological rationale, and established assays. Foreign organizations and foreign components of U.S. organizations are not eligible to apply.
ResearchersSmall businessSchools & universitiesNarrow eligibilityResearch Grants in Clinical Informatics (R01 Clinical Trial Optional)
Due Mar 5, 2029National Institutes of Health · Up to $250K
This NIH/NLM R01 grant funds research teams developing and evaluating clinical informatics tools and methods that turn health data (such as electronic health records, clinical notes, and imaging) into actionable knowledge. Both U.S. and foreign organizations are eligible to apply, but applications involving funded foreign subawards/subcontracts will be rejected under NIH's post-May-2025 policy. The award ceiling is up to about $250,000.
ResearchersSchools & universitiesBroad eligibilityAdvancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)
Due Mar 5, 2029National Institutes of Health · Up to $250K
This NIH/NLM R01 grant supports research advancing bioinformatics, translational bioinformatics, and computational biology, including AI and machine-learning methods for interpreting large biological datasets. Both U.S. and foreign organizations may apply, but applications that include funded foreign subawards/subcontracts will be deemed noncompliant and not considered. The award ceiling is up to about $250,000.
ResearchersSchools & universitiesBroad eligibilityPaul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed)
Due Mar 12, 2029National Institutes of Health · Amount varies
This NIH (K12) career development award supports institutions in training clinician-scientists for clinical and translational cancer research. It is an institutional mentored program; scholars may gain experience in a mentor-led clinical trial but may not lead an independent clinical trial. Only domestic U.S. organizations may apply, foreign organizations are not eligible, though foreign components are allowed. It primarily suits academic medical centers and research institutions building oncology research careers.
Schools & universitiesResearchersNarrow eligibilityScience Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)
Due Mar 16, 2029National Institutes of Health · Amount varies
This NIH (R03) award helps investigators enter high-priority substance use research, including HIV comorbidity, by funding the collection of preliminary data to support future larger grants and career advancement. Eligibility is comparatively open for NIH: foreign organizations and foreign components of U.S. organizations are both eligible to apply, and foreign components are allowed. It suits researchers and institutions transitioning into substance use research fields. No specific award amount is listed.
ResearchersSchools & universitiesNIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
Due Apr 5, 2029National Institutes of Health · Amount varies
This NIH SBIR Phase IIB award is restricted to U.S. small business concerns that have previously received an NIH SBIR or STTR Phase II award; it bridges the gap between Phase II and commercialization for later-stage R&D. Only one such award is allowed per project, and applications must be submitted within the first six due dates after the Phase II budget period ends, so it is narrow and limited to existing grantees. Foreign organizations are not eligible to apply.
Small businessNarrow eligibilitySBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Due Apr 5, 2029National Institutes of Health · Amount varies
This NIH SBIR/STTR Commercialization Readiness Pilot (CRP) is restricted to U.S. small business concerns (as defined by the SBA) and helps move NIH-funded SBIR/STTR projects from late-stage development toward commercialization. It supports later-stage R&D and technical assistance such as replication studies, IND/IDE-enabling work, clinical studies, manufacturing scale-up, and regulatory support, and a significant portion may be subcontracted. Foreign organizations are not eligible to apply.
Small businessNarrow eligibilityPredoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)
Due Apr 8, 2029National Institutes of Health · Amount varies
This NIH Predoctoral-to-Postdoctoral Transition Award (F99/K00) supports promising graduate students as they finish doctoral research and move into mentored postdoctoral career development, in NIH mission-relevant fields. It is a mentored training award administered through institutions; candidates may not lead an independent clinical trial but may participate in a sponsor-led one. Only domestic U.S. organizations may apply; foreign organizations are not eligible, though foreign components are allowed.
Schools & universitiesResearchersNarrow eligibilityNIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed)
Due May 5, 2029National Institutes of Health · Amount varies
This NIH Research Education Program (R25/UE5) funds mentoring activities and networks that develop the biomedical, behavioral, and clinical research workforce. It requires institutional commitment of staff, facilities, and resources, and proposed activities must be distinct from any existing federally funded training programs (such as T32) at the applicant. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityNIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed)
Due May 5, 2029National Institutes of Health · Amount varies
This NIH Research Education Program (R25) funds hands-on research experiences that help build and diversify the biomedical, behavioral, and clinical research workforce. It is aimed at institutions that can provide the staff, facilities, and educational resources to run such programs, and proposed activities must be distinct from any existing federally funded training grants (such as T32). Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityNIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)
Due May 7, 2029National Institutes of Health · Amount varies
This NIH parent opportunity supports research projects built around international collaborations between a U.S. (domestic prime) organization and foreign partners, and at least one international subproject is required. Only domestic U.S. organizations may apply as the prime; non-U.S. entities cannot apply directly, though funded foreign components are allowed. It is aimed at research institutions and universities pursuing health-related projects that need talent, populations, or resources found in other countries. Applicants should expect to manage a linked prime-and-foreign-subaward structure.
Schools & universitiesResearchersNarrow eligibilityBiological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)
Due May 7, 2029National Institutes of Health · Amount varies
This NIH (X01) opportunity does not provide cash funding but instead grants investigators access to services from a state-of-the-art Biological Testing Facility to advance contraceptive development or reproductive health research. Applicants do not need current NIH funding, though priority may go to programs already receiving NIH support. Notably, foreign organizations are eligible to apply, but foreign components of U.S. organizations and foreign components in general are not allowed. It suits researchers needing specialized biological testing resources.
ResearchersSchools & universitiesNarrow eligibilityNIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
This NIH/NIAID Program Project (P01) opportunity funds multi-component research programs in infectious disease and immunology, including HIV, immune dysfunction, allergy, autoimmunity, and vaccine/therapeutic/diagnostic development. Each application must include at least two related research projects plus an administrative core, so it is geared toward research institutions with established teams. Only domestic U.S. organizations may apply; foreign organizations are not eligible, though foreign components are allowed. Clinical trials are not permitted under this NOFO.
Schools & universitiesResearchersNarrow eligibilityNIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
This NIH Research Education Program (R25) funds the development of courses, curricula, and educational methods that strengthen the biomedical, behavioral, and clinical research workforce. It is aimed at institutions that can commit staff, facilities, and educational resources, and proposed activities must be distinct from any existing federally funded training grants (such as T32) at the applicant. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityNIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
This NIH/NIAID Resource-Related Research Project (R24) opportunity funds the creation or support of shared scientific resources that benefit high-priority research in infectious disease and immunology. NIAID expects to use it infrequently, only when other funding mechanisms are not appropriate, so it is a narrow opportunity for research institutions. Only domestic U.S. organizations may apply; foreign organizations are not eligible, though foreign components are allowed, and clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityLimited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
This NIH award is open only to U.S. institutions located in IDeA-eligible states/jurisdictions (a fixed list including Alaska, Arkansas, Delaware, Hawaii, Kentucky, Mississippi and others) that grant doctoral degrees in health-related sciences or are NIH-funded biomedical research institutes. It funds the expansion and sustainability of existing Centers of Biomedical Research Excellence, building faculty, research projects, and core facilities. Eligibility is narrow: it is a limited competition by invitation, applicants may hold no more than three active COBRE awards, and foreign organizations and foreign components are not eligible.
Schools & universitiesResearchersNarrow eligibilityNIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
The NIH Science Education Partnership Award (SEPA, R25) funds educational projects that increase understanding of biomedical research among pre-college (pre-K through grade 12) students and encourage interest in STEM careers. It suits universities, research institutions, and education-focused organizations that can run science education programs. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesNonprofitsNarrow eligibility
Page 16 of 30
How many National Institutes of Health grants are open right now?
UseGrants is tracking 598 open National Institutes of Health opportunities. The next one closes Jan 29, 2029. The largest published award ceiling on this page is $250,000. The list is rebuilt from public records daily, so an opportunity drops off it the day its deadline passes.
Who can apply for National Institutes of Health funding?
Eligibility is set per opportunity, not per agency — the same funder will run one program open to any nonprofit and another restricted to accredited universities. Across the National Institutes of Health opportunities listed here the recurring eligibility signals are researchers, schools & universities, narrow eligibility and small business. Every listing still states its own terms in plain English; confirm them on the funder's official notice before you apply.